IMO recently announced a partnership with Wisconsin-based Redox to standardize clinical data from diverse systems. The partnership enables healthcare companies to spend more time building improved patient and clinician experiences by eliminating the lengthy and taxing process of combining multiple point solutions.
“Clinical patient data is a powerful resource in healthcare. IMO partnering with Redox will accelerate the ability for healthcare companies to leverage that data to create better outcomes for doctors and patients,” said IMO CEO Ann Barnes.
This collaboration is exciting for health IT because it helps to address growing data quality issues throughout the industry. While the amount of healthcare data is enormous and expanding, poor data quality can limit the potential of rapidly advancing technology. Rather than spending significant time, effort, and cost to improve the usability of this data, companies can now work with the tools that were designed to address this burden.